A drug and consumer products company has been ordered to pay Sh473 billion to 22 women who claim the firm’s powder contributed to them developing ovarian cancer.
Uncover the stories others won’t tell. Subscribe now for exclusive access
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted